Alexander Limjuco, MD
Otolaryngology · Bethlehem, PANPI 1679839922
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,716 of the $15,463 with a category attached, or 82.2%. 33 manufacturers reported payments, led by Medtronic at 24.4% of the total. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $49.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Neurent Medical Limited$3K
- Sanofi$1K
- GSK$1K
- Optinose US, Inc.$744
- Aerin Medical Inc.$721
- plus $5K from 27 others
What the payments were for
- Travel & lodging$2,64517%
- Food & beverage$12,71682%
- Education$981%
- Gifts$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 38 | $3,772 |
| Neurent Medical Limited | 41 | $3,088 |
| Sanofi | 44 | $1,261 |
| GSK | 38 | $1,197 |
| Optinose US, Inc. | 26 | $744 |
| Aerin Medical Inc. | 14 | $721 |
| 3-d Matrix, Inc. | 2 | $680 |
| Acclarent, Inc | 8 | $665 |
| Medical Device Business Services, Inc. | 7 | $656 |
| Regeneron Healthcare Solutions, Inc. | 17 | $597 |
| CSL Behring | 17 | $503 |
| Intersect ENT, Inc. | 4 | $236 |
| AstraZeneca | 8 | $205 |
| Pfizer | 10 | $159 |
| Inspire Medical Systems, Inc. | 1 | $107 |
| Preceptis Medical, Inc. | 1 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $103 |
| Phathom Pharmaceuticals, Inc. | 5 | $98 |
| Stryker | 4 | $92 |
| Biocryst US Sales Co., LLC | 2 | $72 |
| AbbVie | 2 | $50 |
| Organogenesis Inc. | 1 | $46 |
| Alk-abello, Inc | 3 | $41 |
| Grifols USA, LLC | 2 | $39 |
| Amgen | 2 | $36 |
| Merck | 2 | $32 |
| Aimmune Therapeutics, Inc. | 2 | $31 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Pharming Healthcare, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROMARK Radiofrequency Console$1,792
- NEUROMARK Device$1,448
- PROPEL$1,077
- STEALTHSTATION S8 PLATFORM$1,019
- NUCALA$491
- ACCLARENT Balloon Inflation Device$422
- Xhance$353
- NEUROMARK System$344
- VIVAER STYLUS$282
- RHINAER STYLUS$282
- DUPIXENT$250
- Hummingbird Tympanostomy Tube System$210
- NIM-RESPONSE$143
- Vivaer RF Stylus$122
- Inspire$107
- NIM Vital$101
How this compares
$15,463 in reported general payments places this provider in the 90th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 11 | $41,436 |
| XhanceFluticasone Propionate | 19 | $15,433 |
| Ipratropium Bromide | 110 | $3,128 |
| Famotidine | 133 | $2,228 |
| Omeprazole | 102 | $1,832 |
| Mometasone Furoate | 22 | $1,814 |
| Fluticasone Propionate | 88 | $1,093 |
| Pantoprazole Sodium | 52 | $525 |
| Fluocinolone Acetonide Oil | 12 | $506 |
| Azelastine Hcl | 18 | $484 |
| Nortriptyline Hcl | 21 | $481 |
| Doxycycline Hyclate | 33 | $330 |
| Methylprednisolone | 31 | $294 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $221 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $744 | $15,43319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 456 otolaryngology providers in Pennsylvania.
Other otolaryngology in Bethlehem
- David YenBethlehem$1.4M
- Aaron JaworekBethlehem$7K
- Jacquelyn MichalskiBethlehem$7K
- David BrownBethlehem$7K
- Glenn KayeBethlehem$6K
- Nancy SnydermanPhiladelphia$4.5M
- David KennedyPhiladelphia$603K
- Stella LeePittsburgh$438K
- James PalmerPhiladelphia$331K
- Ryan SooseSeven Fields$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.